Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sheehan

Showing results (31-40 of 195) with videos related to

Pageof 20
Sort By:
Innovations in Clinical Neuroscience|December 19, 2014
Is There Value in Asking the Question "Do you think you would be better off dead?" in Assessing Suicidality? A Case StudyJennifer M Giddens, David V Sheehan
International Clinical Psychopharmacology|February 28, 2008
Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability ScaleKathy Harnett Sheehan, David V Sheehan
Psychopharmacology Bulletin|October 1, 1982
Diagnostic classification of anxiety and phobic disordersD V Sheehan, K H Sheehan
International Journal of Psychiatry in Medicine|January 1, 1982
The classification of phobic disordersD V Sheehan, K H Sheehan
Journal of Clinical Psychopharmacology|December 1, 1982
The classification of anxiety and hysterical states. Part II. Toward a more heuristic classificationD V Sheehan, K H Sheehan
Psychopharmacology Bulletin|February 8, 2007
Current approaches to the pharmacologic treatment of anxiety disordersDavid V Sheehan, Kathy Harnett Sheehan
Dental Clinics of North America|October 1, 1988
Differentiating anxiety-panic disorders from psychologic dental anxietyA A Weiner, D V Sheehan
Innovations in Clinical Neuroscience|December 19, 2014
Is a count of suicidal ideation and behavior events useful in assessing global severity of suicidality? A case studyJennifer M Giddens, David V Sheehan
The Medical Clinics of North America|May 15, 2001
Social anxiety disorderB A Raj, D V Sheehan
Psychopharmacology Bulletin|October 21, 2003
Paroxetine treatment of generalized anxiety disorderDavid V Sheehan, C Gloria Mao
Pageof 20

Showing results (31-40 of 195) with videos related to

Sort By:
Pageof 20
Innovations in Clinical Neuroscience|December 19, 2014
Is There Value in Asking the Question "Do you think you would be better off dead?" in Assessing Suicidality? A Case StudyJennifer M Giddens, David V Sheehan
International Clinical Psychopharmacology|February 28, 2008
Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability ScaleKathy Harnett Sheehan, David V Sheehan
Psychopharmacology Bulletin|October 1, 1982
Diagnostic classification of anxiety and phobic disordersD V Sheehan, K H Sheehan
International Journal of Psychiatry in Medicine|January 1, 1982
The classification of phobic disordersD V Sheehan, K H Sheehan
Journal of Clinical Psychopharmacology|December 1, 1982
The classification of anxiety and hysterical states. Part II. Toward a more heuristic classificationD V Sheehan, K H Sheehan
Psychopharmacology Bulletin|February 8, 2007
Current approaches to the pharmacologic treatment of anxiety disordersDavid V Sheehan, Kathy Harnett Sheehan
Dental Clinics of North America|October 1, 1988
Differentiating anxiety-panic disorders from psychologic dental anxietyA A Weiner, D V Sheehan
Innovations in Clinical Neuroscience|December 19, 2014
Is a count of suicidal ideation and behavior events useful in assessing global severity of suicidality? A case studyJennifer M Giddens, David V Sheehan
The Medical Clinics of North America|May 15, 2001
Social anxiety disorderB A Raj, D V Sheehan
Psychopharmacology Bulletin|October 21, 2003
Paroxetine treatment of generalized anxiety disorderDavid V Sheehan, C Gloria Mao
Pageof 20